Trial intelligence / Profile preview

Bioequivalence study of etoricoxib 120 mg vs ARCOXIA 120 mg in healthy Thai volunteers under fasting

TCTR20180925005Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of etoricoxib in pain (2 arms), sponsored by International Bio Service. Planned start Dec 2018; status: not yet recruiting.

02

Drugs

etoricoxib
03

Conditions

pain

Beyond the preview

Go deeper on TCTR20180925005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180925005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call